Sphingosine 1-phosphate

Sphingosine 1-phosphate is a lipid of Sphingolipids (SP) class. Sphingosine 1-phosphate is associated with abnormalities such as Infection, Painful Bladder Syndrome, Atherosclerosis, Hyperglycemia and Rheumatoid Arthritis. The involved functions are known as Phosphorylation, Regulation, enzyme activity, Energy Absorption and Vascular Permeability. Sphingosine 1-phosphate often locates in Endothelium, Tissue membrane, Vascular System, Protoplasm and Microfilaments. The associated genes with Sphingosine 1-phosphate are MBTPS1 gene, FBXL15 gene, TEK gene, NTRK1 gene and Gene Family. The related lipids are Promega, Lipopolysaccharides, lysophosphatidic acid, Lysophosphatidylcholines and Lysophospholipids. The related experimental models are Knock-out, Mouse Model, Transgenic Model, Disease model and Experimental Autoimmune Encephalomyelitis.

Cross Reference

Introduction

To understand associated biological information of Sphingosine 1-phosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Sphingosine 1-phosphate?

Sphingosine 1-phosphate is suspected in Lymphopenia, Ischemia, Infection, Atherosclerosis, Multiple Sclerosis, Asthma and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Sphingosine 1-phosphate

MeSH term MeSH ID Detail
Retinal Detachment D012163 10 associated lipids
Thrombocythemia, Essential D013920 9 associated lipids
Mycobacterium Infections, Nontuberculous D009165 8 associated lipids
Teratocarcinoma D018243 7 associated lipids
Rhabdomyosarcoma D012208 7 associated lipids
Eye Abnormalities D005124 7 associated lipids
Multiple Sclerosis, Relapsing-Remitting D020529 7 associated lipids
Peripheral Arterial Disease D058729 7 associated lipids
Anemia, Aplastic D000741 6 associated lipids
Ovarian Diseases D010049 5 associated lipids
Per page 10 20 50 100 | Total 101

PubChem Associated disorders and diseases

What pathways are associated with Sphingosine 1-phosphate

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Sphingosine 1-phosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Sphingosine 1-phosphate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Sphingosine 1-phosphate?

Knock-out

Knock-out are used in the study 'Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.' (Kunisawa J et al., 2008), Knock-out are used in the study 'Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.' (Markiewicz M et al., 2011), Knock-out are used in the study 'Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.' (Yang Q, 2007), Knock-out are used in the study 'Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.' (Idzko M et al., 2006) and Knock-out are used in the study 'Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.' (Gratzinger D et al., 2003).

Mouse Model

Mouse Model are used in the study 'Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin.' (Arce FT et al., 2008), Mouse Model are used in the study 'Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.' (Tengood JE et al., 2010), Mouse Model are used in the study 'S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.' (Chang CL et al., 2009), Mouse Model are used in the study 'Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.' (Hughes JE et al., 2008) and Mouse Model are used in the study 'The alliance of sphingosine-1-phosphate and its receptors in immunity.' (Rivera J et al., 2008).

Transgenic Model

Transgenic Model are used in the study 'Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.' (Augé N et al., 2004), Transgenic Model are used in the study 'Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.' (Sabbadini RA, 2011) and Transgenic Model are used in the study 'Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.' (Gault CR and Obeid LM, 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Sphingosine 1-phosphate

Download all related citations
Per page 10 20 50 100 | Total 2896
Authors Title Published Journal PubMed Link
Ogle ME et al. Sphingosine-1-Phosphate Receptor-3 Supports Hematopoietic Stem and Progenitor Cell Residence Within the Bone Marrow Niche. 2017 Stem Cells pmid:28026131
Yung BS et al. Selective coupling of the S1P receptor subtype to S1P-mediated RhoA activation and cardioprotection. 2017 J. Mol. Cell. Cardiol. pmid:28017639
Contaifer D et al. Unsupervised analysis of combined lipid and coagulation data reveals coagulopathy subtypes among dialysis patients. 2017 J. Lipid Res. pmid:27993949
Myśliwiec H et al. Increase in circulating sphingosine-1-phosphate and decrease in ceramide levels in psoriatic patients. 2017 Arch. Dermatol. Res. pmid:27988894
Powell JA et al. Targeting sphingosine kinase 1 induces MCL1-dependent cell death in acute myeloid leukemia. 2017 Blood pmid:27956387
Miyabe C et al. A sphingosine 1-phosphate receptor agonist ameliorates animal model of vasculitis. 2017 Inflamm. Res. pmid:27942751
McLean CJ et al. Characterization of homologous sphingosine-1-phosphate lyase isoforms in the bacterial pathogen Burkholderia pseudomallei. 2017 J. Lipid Res. pmid:27784725
Abraham C et al. Lessons Learned From Trials Targeting Cytokine Pathways in Patients With Inflammatory Bowel Diseases. 2017 Gastroenterology pmid:27780712
Lim J et al. Valproic acid enforces the priming effect of sphingosine-1 phosphate on human mesenchymal stem cells. 2017 Int. J. Mol. Med. pmid:28677769
Pierucci F et al. Non-dioxin-like organic toxicant PCB153 modulates sphingolipid metabolism in liver progenitor cells: its role in Cx43-formed gap junction impairment. 2017 Arch. Toxicol. pmid:27318803
Mitroi DN et al. SGPL1 (sphingosine phosphate lyase 1) modulates neuronal autophagy via phosphatidylethanolamine production. 2017 Autophagy pmid:28521611
Leo A et al. The Sphingosine 1-Phosphate Signaling Pathway in Epilepsy: A Possible Role for the Immunomodulator Drug Fingolimod in Epilepsy Treatment. 2017 CNS Neurol Disord Drug Targets pmid:27823573
Roch L et al. High-Resolution Expression Profiling of Peripheral Blood CD8 Cells in Patients with Multiple Sclerosis Displays Fingolimod-Induced Immune Cell Redistribution. 2017 Mol. Neurobiol. pmid:27631876
Natarajan V et al. Expression profiling of genes regulated by sphingosine kinase1 signaling in a murine model of hyperoxia induced neonatal bronchopulmonary dysplasia. 2017 BMC Genomics pmid:28851267
Hajny S and Christoffersen C A Novel Perspective on the ApoM-S1P Axis, Highlighting the Metabolism of ApoM and Its Role in Liver Fibrosis and Neuroinflammation. 2017 Int J Mol Sci pmid:28749426
Bertlich M et al. Fingolimod (FTY-720) is Capable of Reversing Tumor Necrosis Factor Induced Decreases in Cochlear Blood Flow. 2017 Otol. Neurotol. pmid:28742634
Koch A et al. Vitamin D Supplementation Enhances C18(dihydro)ceramide Levels in Type 2 Diabetes Patients. 2017 Int J Mol Sci pmid:28714882
Wilkerson JL and Mandal NA Angiogenesis Model of Cornea to Understand the Role of Sphingosine 1-Phosphate. 2017 Methods Mol. Biol. pmid:28660590
Onuma T et al. Sphingosine 1-phosphate (S1P) suppresses the collagen-induced activation of human platelets via S1P4 receptor. 2017 Thromb. Res. pmid:28609704
Azimzadeh K et al. Evaluation of plasma sphingosine 1-phosphate, hepcidin and cardiovascular damage biomarkers (cardiac troponin I and homocysteine) in rats infected with brucellosis and vaccinated (Rev-1, RB-51). 2017 Microb. Pathog. pmid:28533142
Alqinyah M et al. Regulator of G Protein Signaling 10 (Rgs10) Expression Is Transcriptionally Silenced in Activated Microglia by Histone Deacetylase Activity. 2017 Mol. Pharmacol. pmid:28031332
Oh YT et al. DR5 suppression induces sphingosine-1-phosphate-dependent TRAF2 polyubiquitination, leading to activation of JNK/AP-1 and promotion of cancer cell invasion. 2017 Cell Commun. Signal pmid:28482915
Fan Q et al. Sphingosine-1-phosphate promotes ovarian cancer cell proliferation by disrupting Hippo signaling. 2017 Oncotarget pmid:28460443
Lafargue A et al. Ionizing radiation induces long-term senescence in endothelial cells through mitochondrial respiratory complex II dysfunction and superoxide generation. 2017 Free Radic. Biol. Med. pmid:28431961
Di Pietro M et al. In vivo intrabursal administration of bioactive lipid sphingosine-1-phosphate enhances vascular integrity in a rat model of ovarian hyperstimulation syndrome. 2017 Mol. Hum. Reprod. pmid:28379469
Schumacher F et al. The sphingosine 1-phosphate breakdown product, (2)-hexadecenal, forms protein adducts and glutathione conjugates in vitro. 2017 J. Lipid Res. pmid:28588048
Feuerborn R et al. High density lipoprotein (HDL)-associated sphingosine 1-phosphate (S1P) inhibits macrophage apoptosis by stimulating STAT3 activity and survivin expression. 2017 Atherosclerosis pmid:28038379
Gudipaty SA and Rosenblatt J Epithelial cell extrusion: Pathways and pathologies. 2017 Semin. Cell Dev. Biol. pmid:27212253
Wang X et al. Sphingosine 1-phosphate alleviates Coxsackievirus B3-induced myocarditis by increasing invariant natural killer T cells. 2017 Exp. Mol. Pathol. pmid:28986246
Werth S et al. Obesity-stimulated aldosterone release is not related to an S1P-dependent mechanism. 2017 J. Endocrinol. pmid:28970286
Du Y et al. Exosomes from Human-Induced Pluripotent Stem Cell-Derived Mesenchymal Stromal Cells (hiPSC-MSCs) Protect Liver against Hepatic Ischemia/ Reperfusion Injury via Activating Sphingosine Kinase and Sphingosine-1-Phosphate Signaling Pathway. 2017 Cell. Physiol. Biochem. pmid:28934733
Kuchler L et al. Elevated intrathymic sphingosine-1-phosphate promotes thymus involution during sepsis. 2017 Mol. Immunol. pmid:28846923
Nicholas SE et al. Unravelling the interplay of sphingolipids and TGF-β signaling in the human corneal stroma. 2017 PLoS ONE pmid:28806736
Lee SY et al. Adipocyte-Specific Deficiency of De Novo Sphingolipid Biosynthesis Leads to Lipodystrophy and Insulin Resistance. 2017 Diabetes pmid:28698261
Hutami IR et al. Fas/S1P crosstalk via NF-κB activation in osteoclasts controls subchondral bone remodeling in murine TMJ arthritis. 2017 Biochem. Biophys. Res. Commun. pmid:28687489
Cannavo A et al. β-Blockade Prevents Post-Ischemic Myocardial Decompensation Via βAR-Dependent Protective Sphingosine-1 Phosphate Signaling. 2017 J. Am. Coll. Cardiol. pmid:28683966
Punsawad C and Viriyavejakul P Reduction in serum sphingosine 1-phosphate concentration in malaria. 2017 PLoS ONE pmid:28666023
Luo J et al. The effects of berberine on a murine model of multiple sclerosis and the SPHK1/S1P signaling pathway. 2017 Biochem. Biophys. Res. Commun. pmid:28655617
Chang CH and Randolph GJ Sphingosine-1-Phosphate as the Lymphocyte's Ticket to Ride and Survive. 2017 Dev. Cell pmid:28633013
Fang R et al. Sphingosine 1-Phosphate Postconditioning Protects Against Myocardial Ischemia/reperfusion Injury in Rats via Mitochondrial Signaling and Akt-Gsk3β Phosphorylation. 2017 Arch. Med. Res. pmid:28625317
Rohrbach T et al. Sphingosine kinase and sphingosine-1-phosphate in liver pathobiology. 2017 Crit. Rev. Biochem. Mol. Biol. pmid:28618839
Vijayan M et al. Sphingosine 1-Phosphate Lyase Enhances the Activation of IKKε To Promote Type I IFN-Mediated Innate Immune Responses to Influenza A Virus Infection. 2017 J. Immunol. pmid:28600291
Becker S et al. Low sphingosine-1-phosphate plasma levels are predictive for increased mortality in patients with liver cirrhosis. 2017 PLoS ONE pmid:28334008
Karunakaran I and van Echten-Deckert G Sphingosine 1-phosphate - A double edged sword in the brain. 2017 Biochim. Biophys. Acta pmid:28315304
Navarrete A et al. A metabolomic approach shows sphingosine 1-phosphate and lysophospholipids as mediators of the therapeutic effect of liver growth factor in emphysema. 2017 J Pharm Biomed Anal pmid:28314215
Shirakawa H et al. Sphingosine-1-phosphate induces Ca signaling and CXCL1 release via TRPC6 channel in astrocytes. 2017 Glia pmid:28300348
Dyckman AJ Modulators of Sphingosine-1-phosphate Pathway Biology: Recent Advances of Sphingosine-1-phosphate Receptor 1 (S1P) Agonists and Future Perspectives. 2017 J. Med. Chem. pmid:28291340
Nielsen OH et al. Sphingosine-1-Phosphate Signaling in Inflammatory Bowel Disease. 2017 Trends Mol Med pmid:28283249
Peyrin-Biroulet L et al. Modulation of sphingosine-1-phosphate in inflammatory bowel disease. 2017 Autoimmun Rev pmid:28279838
Miller M et al. Cutting Edge: Targeting Epithelial ORMDL3 Increases, Rather than Reduces, Airway Responsiveness and Is Associated with Increased Sphingosine-1-Phosphate. 2017 J. Immunol. pmid:28275141
Su K et al. FTY720 Attenuates Angiotensin II-Induced Podocyte Damage via Inhibiting Inflammatory Cytokines. 2017 Mediators Inflamm. pmid:28270699
Serafimidis I et al. Pancreas lineage allocation and specification are regulated by sphingosine-1-phosphate signalling. 2017 PLoS Biol. pmid:28248965
Lee HM et al. Oncogenic S1P signalling in EBV-associated nasopharyngeal carcinoma activates AKT and promotes cell migration through S1P receptor 3. 2017 J. Pathol. pmid:28240350
Rieck M et al. Ceramide synthase 2 facilitates S1P-dependent egress of thymocytes into the circulation in mice. 2017 Eur. J. Immunol. pmid:28198542
Bruno M et al. Sphingosine 1-phosphate signaling axis mediates fibroblast growth factor 2-induced proliferation and survival of murine auditory neuroblasts. 2017 Biochim. Biophys. Acta pmid:28188805
Al Alam N and Kreydiyyeh SI FTY720P inhibits hepatic Na(+)-K(+) ATPase via S1PR2 and PGE2. 2016 Biochem. Cell Biol. pmid:27501354
Fu P et al. Role of Sphingosine Kinase 1 and S1P Transporter Spns2 in HGF-mediated Lamellipodia Formation in Lung Endothelium. 2016 J. Biol. Chem. pmid:27864331
Terashita T et al. Administration of JTE013 abrogates experimental asthma by regulating proinflammatory cytokine production from bronchial epithelial cells. 2016 Respir. Res. pmid:27829417
Dong T et al. Cortisol-induced immune suppression by a blockade of lymphocyte egress in traumatic brain injury. 2016 J Neuroinflammation pmid:27561600
Nojima H et al. Chemokine Receptors, CXCR1 and CXCR2, Differentially Regulate Exosome Release in Hepatocytes. 2016 PLoS ONE pmid:27551720
Harris CM et al. Sphingosine-1-Phosphate (S1P) Lyase Inhibition Causes Increased Cardiac S1P Levels and Bradycardia in Rats. 2016 J. Pharmacol. Exp. Ther. pmid:27519818
Gstalder C et al. FTY720 (Fingolimod) Inhibits HIF1 and HIF2 Signaling, Promotes Vascular Remodeling, and Chemosensitizes in Renal Cell Carcinoma Animal Model. 2016 Mol. Cancer Ther. pmid:27507852
Hashimoto Y et al. Sphingosine-1-phosphate-enhanced Wnt5a promotes osteogenic differentiation in C3H10T1/2 cells. 2016 Cell Biol. Int. pmid:27486054
Viswanathan P et al. Differential elastic responses to barrier-altering agonists in two types of human lung endothelium. 2016 Biochem. Biophys. Res. Commun. pmid:27473658
Moruno Manchon JF et al. SPHK1/sphingosine kinase 1-mediated autophagy differs between neurons and SH-SY5Y neuroblastoma cells. 2016 Autophagy pmid:27467777
Nagahashi M et al. The roles of bile acids and sphingosine-1-phosphate signaling in the hepatobiliary diseases. 2016 J. Lipid Res. pmid:27459945
Rumzhum NN et al. Effect of Sphingosine 1-Phosphate on Cyclo-Oxygenase-2 Expression, Prostaglandin E2 Secretion, and β2-Adrenergic Receptor Desensitization. 2016 Am. J. Respir. Cell Mol. Biol. pmid:26098693
Bao XH et al. [Role and related mechanism of S1P/S1P1 signal pathway during post conditioning of hypertrophic cardiomyocytes]. 2016 Zhonghua Xin Xue Guan Bing Za Zhi pmid:27220580
Marfia G et al. The Adipose Mesenchymal Stem Cell Secretome Inhibits Inflammatory Responses of Microglia: Evidence for an Involvement of Sphingosine-1-Phosphate Signalling. 2016 Stem Cells Dev. pmid:27217090
Versmissen J et al. Familial hypercholesterolaemia: cholesterol efflux and coronary disease. 2016 Eur. J. Clin. Invest. pmid:27208892
Sauvé M et al. Tumor Necrosis Factor/Sphingosine-1-Phosphate Signaling Augments Resistance Artery Myogenic Tone in Diabetes. 2016 Diabetes pmid:27207546
Zhang XE et al. Activation of RhoA, but Not Rac1, Mediates Early Stages of S1P-Induced Endothelial Barrier Enhancement. 2016 PLoS ONE pmid:27187066
Ohtoyo M et al. Component of Caramel Food Coloring, THI, Causes Lymphopenia Indirectly via a Key Metabolic Intermediate. 2016 Cell Chem Biol pmid:27185637
Fleming JK et al. A novel approach for measuring sphingosine-1-phosphate and lysophosphatidic acid binding to carrier proteins using monoclonal antibodies and the Kinetic Exclusion Assay. 2016 J. Lipid Res. pmid:27444045
Barnawi J et al. Pro-phagocytic Effects of Thymoquinone on Cigarette Smoke-exposed Macrophages Occur by Modulation of the Sphingosine-1-phosphate Signalling System. 2016 COPD pmid:27144721
Jin L et al. The SphKs/S1P/S1PR1 axis in immunity and cancer: more ore to be mined. 2016 World J Surg Oncol pmid:27129720
Sanchez T Sphingosine-1-Phosphate Signaling in Endothelial Disorders. 2016 Curr Atheroscler Rep pmid:27115142
Tang X et al. Tetracyclines increase lipid phosphate phosphatase expression on plasma membranes and turnover of plasma lysophosphatidate. 2016 J. Lipid Res. pmid:26884614
Liu W et al. Sphingosine-1-phosphate receptor 2 mediates endothelial cells dysfunction by PI3K-Akt pathway under high glucose condition. 2016 Eur. J. Pharmacol. pmid:26921757
Yang Y et al. Sphingosine kinase inhibition ameliorates chronic hypoperfusion-induced white matter lesions. 2016 Neurochem. Int. pmid:26921668
Park K et al. ER stress stimulates production of the key antimicrobial peptide, cathelicidin, by forming a previously unidentified intracellular S1P signaling complex. 2016 Proc. Natl. Acad. Sci. U.S.A. pmid:26903652
Bien-Möller S et al. Expression of S1P metabolizing enzymes and receptors correlate with survival time and regulate cell migration in glioblastoma multiforme. 2016 Oncotarget pmid:26887055
Uranbileg B et al. Increased mRNA Levels of Sphingosine Kinases and S1P Lyase and Reduced Levels of S1P Were Observed in Hepatocellular Carcinoma in Association with Poorer Differentiation and Earlier Recurrence. 2016 PLoS ONE pmid:26886371
Chumanevich A et al. Sphingosine-1-Phosphate/Sphingosine-1-Phosphate Receptor 2 Axis Can Promote Mouse and Human Primary Mast Cell Angiogenic Potential through Upregulation of Vascular Endothelial Growth Factor-A and Matrix Metalloproteinase-2. 2016 Mediators Inflamm. pmid:26884643
Ko P et al. Extracellular Matrix Rigidity-dependent Sphingosine-1-phosphate Secretion Regulates Metastatic Cancer Cell Invasion and Adhesion. 2016 Sci Rep pmid:26877098
Luo B et al. Erythropoeitin Signaling in Macrophages Promotes Dying Cell Clearance and Immune Tolerance. 2016 Immunity pmid:26872696
Gomez-Muñoz A et al. Control of inflammatory responses by ceramide, sphingosine 1-phosphate and ceramide 1-phosphate. 2016 Prog. Lipid Res. pmid:26703189
Ottenlinger F et al. Fingolimod targeting protein phosphatase 2A differently affects IL-33 induced IL-2 and IFN-γ production in CD8(+) lymphocytes. 2016 Eur. J. Immunol. pmid:26683421
Fan A et al. Liver X receptor-α and miR-130a-3p regulate expression of sphingosine 1-phosphate receptor 2 in human umbilical vein endothelial cells. 2016 Am. J. Physiol., Cell Physiol. pmid:26669941
Petrache I and Berdyshev EV Ceramide Signaling and Metabolism in Pathophysiological States of the Lung. 2016 Annu. Rev. Physiol. pmid:26667073
Delgado A and Martínez-Cartro M Therapeutic Potential of the Modulation of Sphingosine-1-Phosphate Receptors. 2016 Curr. Med. Chem. pmid:26639095
Yamamoto S et al. A role of the sphingosine-1-phosphate (S1P)-S1P receptor 2 pathway in epithelial defense against cancer (EDAC). 2016 Mol. Biol. Cell pmid:26631556
Kakazu E et al. Hepatocytes release ceramide-enriched pro-inflammatory extracellular vesicles in an IRE1α-dependent manner. 2016 J. Lipid Res. pmid:26621917
Chen J et al. Deletion of sphingosine kinase 1 ameliorates hepatic steatosis in diet-induced obese mice: Role of PPARγ. 2016 Biochim. Biophys. Acta pmid:26615875
Tan SF et al. Acid ceramidase is upregulated in AML and represents a novel therapeutic target. 2016 Oncotarget pmid:27825124
Gao D et al. Metabolomics study on the antitumor effect of marine natural compound flexibilide in HCT-116 colon cancer cell line. 2016 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:26859520
Nigro E et al. Role of adiponectin in sphingosine-1-phosphate induced airway hyperresponsiveness and inflammation. 2016 Pharmacol. Res. pmid:26462929
Serdar M et al. Fingolimod protects against neonatal white matter damage and long-term cognitive deficits caused by hyperoxia. 2016 Brain Behav. Immun. pmid:26456693
Arish M et al. Sphingosine-1-phosphate signaling: unraveling its role as a drug target against infectious diseases. 2016 Drug Discov. Today pmid:26456576
Melnik BC Rosacea: The Blessing of the Celts - An Approach to Pathogenesis Through Translational Research. 2016 Acta Derm. Venereol. pmid:26304030